Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria

被引:14
作者
Yang, Shouning [1 ]
Shi, Wei [1 ]
Xing, Dong [1 ]
Zhao, Zheng [2 ]
Lv, Fengping [1 ]
Yang, Liping [1 ]
Yang, Yushe [3 ]
Hu, Wenhao [1 ,3 ]
机构
[1] E China Normal Univ, Dept Chem, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Shanghai 200062, Peoples R China
[2] E China Normal Univ, Minist Educ, Shanghai Key Lab Brain Funct Genom, Key Lab Brain Funct Genom, Shanghai 200062, Peoples R China
[3] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China
关键词
Drug resistant bacteria; Peptide deformylase inhibitor; Proline derivatives; SIDE-CHAIN; PHARMACOKINETICS; BB-3497; LBM415; ACTINONIN; TARGET; AGENTS; MODEL;
D O I
10.1016/j.ejmech.2014.07.106
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Peptide deformylase (PDF) has been identified as a promising target for novel antibacterial agents. In this study, a series of novel formyl hydroxyamino derivatives were designed and synthesized as PDF inhibitors and their antibacterial activities were evaluated. Among the potent PDF inhibitors (1o, 1q, 1o', 1q', and 1x), in vivo studies showed that compound 1q possesses mild toxicity, a good pharmacokinetic profile and protective effects. The good in vivo efficacy and low toxicity suggest that this class of compounds has potential for development and use in future antibacterial drugs. (c) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:133 / 152
页数:20
相关论文
共 46 条
[1]   ON RELEASE OF FORMYL GROUP FROM NASCENT PROTEIN [J].
ADAMS, JM .
JOURNAL OF MOLECULAR BIOLOGY, 1968, 33 (03) :571-&
[2]  
Aubart K, 2006, PROGR MED CHEM, V44, P109, DOI 10.1016/S0079-6468(05)44403-3
[3]  
Axten J.M., 2007, World Patent, Patent No. [W02007016364 A3, 2007016364]
[4]   Efficacy of BB-83698, a novel peptide deformylase inhibitor, in a mouse model of pneumococcal pneumonia [J].
Azoulay-Dupuis, E ;
Mohler, J ;
Bédos, JP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :80-85
[5]   Enantioselective hydrogenation of alpha,beta-unsaturated acids. Substrate-modifier interaction over cinchonidine modified Pd/Al2O3 [J].
Borszeky, K ;
Mallat, T ;
Baiker, A .
TETRAHEDRON-ASYMMETRY, 1997, 8 (22) :3745-3753
[6]   Antibiotics in the clinical pipeline in 2011 [J].
Butler, Mark S. ;
Cooper, Matthew A. .
JOURNAL OF ANTIBIOTICS, 2011, 64 (06) :413-425
[7]  
Chemburkar S.R., 2010, US Patent, Patent No. [US 2011/0065930 A1, 20110065930]
[8]   Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor [J].
Chen, DZ ;
Patel, DV ;
Hackbarth, CJ ;
Wang, W ;
Dreyer, G ;
Young, DC ;
Margolis, PS ;
Wu, C ;
Ni, ZJ ;
Trias, J ;
White, RJ ;
Yuan, ZY .
BIOCHEMISTRY, 2000, 39 (06) :1256-1262
[9]  
Clements John M., 2002, Current Medicinal Chemistry - Anti-Infective Agents, V1, P239, DOI 10.2174/1568012023354866
[10]   Structure-activity relationships of the peptide deformylase inhibitor BB-3497:: Modification of the P2′ and P3′ side chains [J].
Davies, SJ ;
Ayscough, AP ;
Beckett, RP ;
Clements, JM ;
Doel, S ;
Pratt, LM ;
Spavold, ZM ;
Thomas, SW ;
Whittaker, M .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (16) :2715-2718